Sunday, December 22

Tag: Divestments

Wuxi Biologics Unit’s Hong Kong IPO Closes Order Book a Day Early, Sources Say
9Nov By adminNo Comments
World

Wuxi Biologics Unit’s Hong Kong IPO Closes Order Book a Day Early, Sources Say

A unit of Chinese contract drugmaker Wuxi Biologics closed its order book a day early for its initial public offering and is likely to price the deal at the top of its marketed range, people familiar with the matter said, a rare instance of hot demand in a choppy year for listings in Hong Kong.Wuxi XDC Cayman is set to raise the equivalent of about US$470 million if it prices the IPO at the top end of its marketed price range, at 20.60 Hong Kong dollars (US$2.64) a share, the people said. The Wuxi, China-based company does research, development and manufacturing with a focus on antibody-drug conjugate, a type of medicine for cancer treatment.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Vodafone to Sell Spanish Unit to Zegona Communications for Around $5.3 Bln
31Oct By adminNo Comments
World

Vodafone to Sell Spanish Unit to Zegona Communications for Around $5.3 Bln

Updated Oct. 31, 2023 4:07 am ETVodafone Group has agreed to sell its Spanish unit to European telecommunications investment company Zegona Communications for an enterprise value of around 5 billion euros ($5.31 billion).The U.K.-based telecommunications group on Tuesday said the deal is for 100% of Vodafone Spain.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Sanofi Plans to Spin Off Consumer-Healthcare Business
27Oct By adminNo Comments
World

Sanofi Plans to Spin Off Consumer-Healthcare Business

Sanofi said it plans to spin off its consumer-healthcare unit into a publicly listed entity, making it the latest pharmaceutical giant to sharpen its focus on prescription medicines by offloading adjacent businesses.The French company said Friday that the spinoff is part of a strategic update that includes increased investment in its pipeline and a cost-savings plan.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
TotalEnergies Posts Higher 3Q Profit, Increases Dividend
26Oct By adminNo Comments
World

TotalEnergies Posts Higher 3Q Profit, Increases Dividend

TotalEnergies increased shareholder distribution after its third-quarter profit rose, boosted by a supportive price environment.The French oil-and-gas major said quarterly net profit came in at $6.68 billion compared with $6.63 billion in the same period last year. On an adjusted basis, profit was $6.45 billion.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
This $5 Billion Biotech Home Run Took Less Than a Year
25Oct By adminNo Comments
Money

This $5 Billion Biotech Home Run Took Less Than a Year

You can’t completely blame Pfizer’s executives, yet Roche’s $7 billion acquisition of a bowel-disease treatment that it owned until last year isn’t a great look.In a deal that now feels like a biotech version of “Moneyball,” Roivant announced it was selling an asset that only 11 months ago it got for free from Pfizer. (The Wall Street Journal had reported the talks back in July). Big pharma companies focused on the drug industry equivalent of free agent signings will often overlook one of their own hot prospects. In fact, Republican presidential candidate Vivek Ramaswamy founded Roivant on the idea that pharma’s trash can be another company’s treasure. But this one became an almost instant All-Star.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c...
Read More
This $5 Billion Biotech Home Run Took Less Than a Year
24Oct By adminNo Comments
World

This $5 Billion Biotech Home Run Took Less Than a Year

You can’t completely blame Pfizer’s executives, yet Roche’s $7 billion acquisition of a bowel-disease treatment that it owned until last year isn’t a great look.In a deal that now feels like a biotech version of “Moneyball,” Roivant announced it was selling an asset that only 11 months ago it got for free from Pfizer. (The Wall Street Journal had reported the talks back in July). Big pharma companies focused on the drug industry equivalent of free agent signings will often overlook one of their own hot prospects. In fact, Republican presidential candidate Vivek Ramaswamy founded Roivant on the idea that pharma’s trash can be another company’s treasure. But this one became an almost instant All-Star.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c...
Read More
Goldman Sachs, Pulling Back From Consumer Lending, Posts 33% Profit Drop
17Oct By adminNo Comments
World

Goldman Sachs, Pulling Back From Consumer Lending, Posts 33% Profit Drop

Updated Oct. 17, 2023 10:16 am ETGoldman Sachs reported lower profit for the third quarter, hurt by losses from selling off pieces of its consumer-lending business and a big drop in revenue in its asset and wealth-management division.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Goldman Sachs, Pulling Back From Consumer Lending, Posts 33% Profit Drop
17Oct By adminNo Comments
Money

Goldman Sachs, Pulling Back From Consumer Lending, Posts 33% Profit Drop

Updated Oct. 17, 2023 10:16 am ETGoldman Sachs reported lower profit for the third quarter, hurt by losses from selling off pieces of its consumer-lending business and a big drop in revenue in its asset and wealth-management division.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More